![]() |
|
|
Vol. 291, Issue 2, 555-561, November 1999
Department of Physiological Sciences, University of Florida, College of Veterinary Medicine, Gainesville, Florida
| |
Abstract |
|---|
|
|
|---|
The interaction of the cysteine conjugate S-(1-chloro-1,2,2,-trifluoroethyl)-L-cysteine (CTFC) with organic anion and amino acid transport in the basolateral and apical membranes was examined with rabbit renal proximal tubule suspensions and primary cultures of rabbit renal proximal tubule cells. The apparent Ki for CTFC inhibition of the 1-min uptake of [3H]p-aminohippurate in tubule suspensions was 105 ± 3 µM and suggests that CTFC interacts with basolateral organic anion transport. Also, the addition of 1 mM CTFC decreased the secretion and intracellular accumulation of fluorescein by ~70 to 75%. The addition of 1 mM CTFC to the apical compartment decreased the reabsorption and intracellular accumulation of the amino acid [3H]phenylalanine by ~60 to 70%. Similar to CTFC, saturating concentrations of the organic anion [3H]p-aminohippurate and the amino acid phenylalanine reduced by ~75% fluorescein secretion and [3H]phenylalanine reabsorption, respectively, by ~60 to 70%. Thus, the cysteine conjugate CTFC appears to be a potent inhibitor of basolateral organic anion and apical amino acid transepithelial transport. In contrast to its effects on apical phenylalanine uptake, CTFC had no effect on the basal uptake of [3H]phenylalanine by primary cultures. The presence of CTFC in the external bath did trans-stimulate the efflux of fluorescein and [3H]phenylalanine across the basal and apical membrane in tubule suspensions or primary cultures, respectively, grown on plastic. Collectively, these data demonstrate that CTFC interacts with, and is transported by, two anatomically and functionally distinct transporters, the basolateral organic anion and apical neutral amino acid pathways, in the rabbit renal proximal tubule cell.
| |
Introduction |
|---|
|
|
|---|
The
haloalkane cysteine conjugate
S-(1-chloro-1,2,2-trifluoroethyl)-L-cysteine
(CTFC) produces cell injury and death to suspensions of rabbit renal
proximal tubules (RPTs) (Groves, 1991
; Groves et al.,
1991a
). Differences were found to exist in the mechanism by which the
haloalkane cysteine conjugates CTFC and
S-(1,1,2,2-tetrafluoroethyl)-L-cysteine (TFEC) produce cell injury in suspensions of rabbit RPT compared with
the haloalkene cysteine conjugates
S-(1,2-dichlorovinyl)-L-cysteine (DCVC) and
S-(1,2,3,4,4-pentachlorobutadienyl)-L-cysteine
(PCBC) (Groves, 1991
; Groves et al., 1991a
,b
, 1993
). In spite of their structural similarities, aminooxyacetic acid, the inhibitor of cysteine
conjugate
-lyase, completely prevented TFEC- and CTFC-induced cytotoxicity to tubule suspensions. However, aminooxyacetic acid had no
effect on DCVC-induced toxicity and delayed but did not prevent
PCBC-induced toxicity to tubule suspensions (Groves et al., 1991a
,b
,
1993
). The differences in the response of the renal cell to these
toxicants may exist at the level of transport as well. The ability of
these toxicants to cross the renal membrane and enter the renal cell
appears to be paramount to the production of cytotoxicity. Thus, the
presence of various transport pathways within the RPT for toxicant
uptake and accumulation may play an important role in the target-organ
selectivity of cysteine conjugates.
Cysteine conjugates enter the renal cell by various transport pathways
in the RPT membrane (Schaeffer and Stevens, 1987a
,b
; Lash and Anders,
1989
; Mertens et al., 1990
; Chakrabarti et al., 1991
). One such
pathway, the organic anion transport system, serves as a mechanism to
transport and accumulate various exogenous and potentially toxic
substances by the RPT cell. The peritubular membrane organic anion
transporter mediates the transport of the cysteine conjugate DCVC in
rabbit S2 segments (Dantzler et al., 1998
). In contrast, apical DCVC
transport in rabbit and rat renal cortical brush-border membrane
vesicles (BBMVs), as well as in LLC-PK1 cells, involves the
neutral amino acid transporter (Schaeffer and Stevens, 1987a
,b
; Wright
and Wunz, 1998
). The ability of CTFC to block the uptake of DCVC in
LLC-PK1 cells or rat RPT cells suggests that these cysteine conjugates
may interact with a common transport pathway (Schaeffer and Stevens,
1987a
; Lash and Anders, 1989
). However, studies have not demonstrated
whether the pathways that transport DCVC also transport CTFC.
Although the presence of probenecid blocked the toxicity of DCVC in rat
RPT cells (Lash and Anders, 1986
), no protective effect of probenecid
on CTFC- and TFEC-induced cytotoxicity in this model was detected
(Boogaard et al., 1989
). In contrast, probenecid was reported to reduce
the cytotoxicity associated with exposure of rat RPT cells to the
mercapturic acid conjugates of CTFC and TFEC (Boogaard et al., 1989
).
Thus, the differences in the response of the renal cell to these
toxicants may also exist at the level of transport. The objective of
this study was to examine the interaction of the cysteine conjugate
CTFC with the organic anion and neutral amino acid transport pathways
in the basolateral and apical membranes of the RPT cell. The model
systems used in the study were primary cultures of rabbit RPT cells
grown on permeable and impermeable membrane surfaces and suspensions of
rabbit RPT.
| |
Experimental Procedures |
|---|
|
|
|---|
Animals and Materials.
New Zealand White rabbits of either
sex were purchased from Big D Rabbitry (Dade City, FL). Unlabeled
phenylalanine, [3H]phenylalanine (50 Ci/mmol),
p-aminohippurate (PAH), and fluorescein were purchased
from Sigma Chemical Co. (St. Louis, MO).
S-(1-Chloro-1,2,2-trifluoroethyl)-L-cysteine was a generous gift from Dr. Stephen Hasal (Tucson, AZ). All other chemicals were purchased from standard sources as reported previously (Groves et al., 1994
, 1999
) and were of the highest quality available.
Isolation of Proximal Tubule Suspensions and Culture
Conditions.
An in vitro perfusion with iron oxide as described
previously (Groves and Schnellmann, 1996
) was used for the
isolation and purification of rabbit RPT. For transport studies with
suspensions of rabbit RPT, the final tubule pellet was resuspended at a
protein concentration of 1 mg/ml. Tubules were resuspended in an
incubation medium containing: 110 mM NaCl, 25 mM NaHCO3, 5 mM KCl, 2 mM NaH2PO4, 1 mM MgSO4,
1.8 mM CaCl2, 10 mM sodium acetate, 8.3 mM
D-glucose, 5 mM alanine, 0.9 mM glycine, 1.5 mM lactate, 1 mM malate, and 1 mM sodium citrate (pH 7.4, 295 mOsm/kg).
Tubular protein was measured with a Bio-Rad Laboratories, Inc.
(Richmond, CA) protein assay with a BSA standard.
Measurement of Paracellular Inulin Flux in Primary Cultures. The movement of fluorescein isothiocyanate-inulin (FL-I) diffusion across the monolayer was measured to evaluate monolayer permeability. Culture medium was removed, incubation medium containing 100 µM (final concentration) FL-I was added to the basal or apical compartments, and incubation medium alone was added to the opposite compartment. Cultures were incubated at 37°C as described above. At timed intervals up to 2 h, aliquots (100 µl) were removed from both compartments, and FL-I fluorescence (filter pair: 485 nm excitation, 538 nm emission) determined with a Molecular Devices (Sunnyvale, CA) Fmax fluorescence microplate reader.
Measurement of Transport in Suspensions of RPT.
Tubule
suspensions (1 mg/ml) were preincubated in Erlenmeyer flasks for 15 min
at 37°C and were gassed with 95% O2/5% CO2. To measure tubular efflux, fluorescein (4 µM final concentration) was
added to the suspension and incubated for 5 min. After the desired
incubation, 0.25-ml aliquots of the suspension were removed and added
to a 15-ml polypropylene tube containing 5 ml of ice-cold incubation
buffer to stop uptake. Samples were immediately centrifuged for ~30 s
at 1480g to pellet the tubules. The supernatant fraction was aspirated, and the pellet was rinsed a second time. The samples were frozen for ~12 h at
20°C to lyse the cells and subsequently thawed by adding 1.5 ml of ddH2O. The pellet was
vortexed for ~60 s and centrifuged at 1480g for 5 min.
Aliquots (100 µl) were transferred to a 96-well plate, and
fluorescein fluorescence was then measured with an
Fmax fluorescence microplate reader (filter pair: 485 nm excitation, 538 nm emission). The amount of accumulated fluorescence represented time 0 fluorescein content at the start of the
efflux period. A 0.25-ml aliquot of the tubule suspension was
transferred to a tube containing 2.5 ml of either incubation medium
alone or 1 mM PAH or CTFC. The incubation was continued for 1 min,
during which fluorescein was typically lost from the tubules to the
bath. At the end of the efflux period, 5 ml of ice-cold incubation
buffer was added to terminate the reaction, and the tubule pellets were
prepared for measuring intracellular fluorescence as described.
Measurement of Transport in Primary Cultures.
The
interaction of CTFC with the transepithelial transport of fluorescein
or [3H]phenylalanine was studied in confluent cultures
(day 4-5) grown on permeable membranes. Confluence was assessed by
phase-contrast microscopy and measurement of the diffusion of
fluorescein-inulin as described by Groves et al. (1999)
. For
basal-to-apical transepithelial organic anion flux studies, 2.5 ml of
an incubation medium containing 4 µM 4 µM fluorescein in the
presence or absence of 1 mM CTFC or 2.5 mM PAH was added to the basal
compartment, and incubation buffer alone was added to the
trans-compartment. Cultures were incubated in a
humidified incubator under a 95% air/5% CO2 atmosphere at
37°C and were constantly swirled on an orbital shaker (80-85 rpm).
At timed intervals up to 2 h, 100-µl aliquots of the incubation medium were removed from the apical and basal compartments and transferred to an Fmax fluorescence
microplate reader for measurement of fluorescein fluorescence. To
measure intracellular accumulation of fluorescein at the end of the
incubation for transepithelial flux measurements, cultures were washed
twice with ice-cold incubation buffer, and the membranes were removed
and transferred to scintillation vials. Cells were frozen at
20°C
for 12 h and lysed by thawing in the presence of 1 ml of
ddH2O. A 100-µl aliquot was removed, and the
intracellular accumulation of fluorescein by the cultures was
determined with an Fmax microplate reader as
described. The autofluorescence of control cultures not incubated with
fluorescein or CTFC was subtracted from the total fluorescence of
treated cultures.
Calculations of Fluorescein and Phenylalanine Clearance.
The
transepithelial flux of fluorescein and [3H]phenylalanine
in the presence and absence of CTFC, PAH, or phenylalanine was expressed as clearance units. The clearance is defined as the volume of
medium that is totally cleared of the test substrate at a time
t, normalized to the surface area (4.7 cm2)
of the permeable membrane. The transepithelial movement of substrate from the basal-to-apical or apical-to-basal compartments was calculated and expressed as clearance by the following equations:
|
(1) |
|
(2) |
Statistics. Data are presented as means ± S.E. Each preparation of tubules from a single rabbit represented a separate experiment. Data from three or four separate experiments were compared for statistical significance with a paired t test, ANOVA, and a posttest with Fisher's protected least-significant-difference method and a value of p < .05.
| |
Results |
|---|
|
|
|---|
Inhibition of Basolateral PAH Uptake by CTFC.
As shown in Fig.
1, increasing concentrations of CTFC
progressively reduced the uptake of [3H]PAH with maximal
inhibition produced by CTFC concentrations >0.5 mM. However, the
highest concentrations of CTFC did not completely block the uptake of
[3H]PAH, which is consistent with the presence of
diffusion, and/or nonspecific binding. The inhibition of PAH uptake
with only 1 min of exposure to various CTFC concentrations supports the
conclusion that CTFC inhibited the carrier-mediated transport of PAH.
The inhibition of [3H]PAH uptake by CTFC was described by
the kinetics of competitive inhibition with the isotope-dilution
procedure as described previously by Groves et al. (1994
, 1995
) and
Dantzler et al. (1998)
. With the data in Fig. 1, the calculated
inhibition constant (Ki) value for CTFC
inhibition of [3H]PAH uptake was 105 ± 3 µM,
which is similar to the Km of 165 µM for
basolateral PAH transport in S2 segments of rabbit RPT (Dantzler et
al., 1995
). Also with concentrations of DCVC similar to those
used for CTFC in this study, Dantzler et al. (1995)
measured a
Ki of 86 µM for the inhibition of PAH
uptake by DCVC in rabbit S2 segments. Because both PAH and DCVC are
substrates for the organic anion transporter (Dantzler et al., 1995
,
1998
), these observations collectively suggest that CTFC also interacts
with the organic anion transport pathway in the basolateral membrane.
|
CTFC Interaction with Basal-to-Apical Flux and Basolateral Uptake
of Fluorescein.
Based on a Ki of 105 µM as measured for CTFC inhibition of PAH uptake, a concentration of
1 mM CTFC would be expected to reduce the basal-to-apical flux and
intracellular accumulation of organic anion substrates by ~70% or
more through a specific interaction with the basolateral organic anion
transporter. As shown in Fig. 2, the flux
of 4 µM fluorescein through ~2 h was reduced ~75 to 80% at all
time points examined in the presence of 2.5 mM PAH or 1 mM CTFC.
Because transepithelial flux involves substrate transport across two
separate membranes, blocking its entry into the cell or its exit from
the cell can reduce the transepithelial flux of fluorescein. The
intracellular uptake and accumulation of fluorescein from the basal
compartment, measured after 2 h of incubation, also was reduced
~70% by the addition of 1 mM CTFC or 2.5 mM PAH to the basal
compartment (Fig. 3). The inhibition of
the basal-to-apical flux and accumulation of fluorescein produced by 1 mM CTFC was not statistically different from the inhibition produced by
2.5 mM PAH, which suggests that CTFC, like PAH, reduced the
basal-to-apical flux and uptake of fluorescein by blocking the
basolateral membrane organic anion pathway. The basal-to-apical transepithelial flux of fluorescein was more than 10-fold greater than
the reabsorptive flux (data not shown). Because the apical uptake of
fluorescein was minimal, this event did not contribute significantly to
organic anion transport in primary cultures and would likely play only
a minor role in CTFC transport.
|
|
CTFC Interaction with Apical-to-Basal Flux and Apical Uptake of
Phenylalanine.
The flux of [3H]phenylalanine (0.1 µCi/ml) from the apical to the basal compartments increased with time
and was linear for ~2 h. In the presence of 10 mM phenylalanine or 1 mM CTFC, the apical-to-basal flux of [3H]phenylalanine
was reduced ~75 to 80% during the 2-h incubation (Fig.
4). To determine whether the inhibition
of [3H]phenylalanine flux by CTFC was caused by
inhibition of apical uptake or basal efflux, the effect of CTFC on the
intracellular accumulation of [3H]phenylalanine was
measured. The intracellular accumulation of [3H]phenylalanine from the apical compartment, measured
after 2 h of incubation, also was reduced ~70 and 95% by the
addition of 1 mM CTFC or 10 mM phenylalanine, respectively, to the
apical compartment (Fig. 5). In contrast,
the addition of 1 mM CTFC to the basal compartment had no effect on the
intracellular uptake and accumulation of
[3H]phenylalanine from the basal compartment by primary
cultures, whereas accumulation was reduced ~95% by unlabeled
phenylalanine (Fig. 5).
|
|
Trans-Stimulation of Substrate Efflux by CTFC.
The ability of a substrate to inhibit the uptake or transepithelial
flux of a second substrate is merely indicative of some type of
interaction of the inhibitor with a transporter. An indicator used
frequently to determine whether two substrates share a common transport
pathway is to demonstrate the ability of a substrate present on one
face of the membrane to stimulate the flux of a second substrate from
the opposite face (i.e., trans-membrane surface) of the
membrane. Because rabbit RPT suspensions provide an excellent model for
study of basolateral transport due to the presence of collapsed lumens
(Groves et al., 1994
; Groves and Wright, 1995
; Dantzler et al.,
1998
), tubule suspensions were used for fluorescein efflux
studies (Fig. 6). The ability of CTFC present in the external bath to trans-stimulate the
basolateral membrane efflux of fluorescein was examined with
fluorescein-preloaded suspensions of rabbit RPT (Fig. 6). When either 1 mM CTFC or 1 mM PAH was present on the trans-membrane
surface, ~70% of the accumulated fluorescein was lost during the
1-min efflux period, compared to ~50% fluorescein loss from tubules
incubated with buffer containing no substrate (0 trans).
The efflux of fluorescein in the presence of 1 mM CTFC or 1 mM PAH was
significantly greater than the 0-trans condition, which
reflects a trans-stimulation of efflux by these
substrates, presumably because of increased turnover of the carrier
caused by the mediated uptake of the external substrate.
|
|
| |
Discussion |
|---|
|
|
|---|
In primary cultures of rabbit RPT cells, the cysteine conjugate CTFC interacts with two functionally and anatomically distinct transport processes located in the apical and basolateral membranes. The inhibition of the basal-to-apical and apical-to-basal transepithelial fluxes of fluorescein and phenylalanine, respectively, by CTFC were similar to those produced by saturating concentrations of PAH and phenylalanine, respectively. Thus, organic anion or amino acid transport across both poles of the renal cell is significantly reduced by the addition of CTFC to the basal or apical compartment and suggests that CTFC interacts with these transport systems.
Although the observed inhibition of transport could reflect an indirect
effect on transport such as disruption of the Na gradient, the ability
of increasing CTFC concentrations to progressively inhibit the 1-min
uptake of PAH at the basolateral membrane in RPT suspensions also
demonstrates a specific interaction of CTFC with the organic anion
transporter. During such a short incubation with CTFC, toxicity is
unlikely. However, this conjugate was a potent inhibitor of
[3H]PAH uptake in RPT suspensions with a
Ki of 105 µM, a value similar to the
Ki of 86 µM for inhibition of PAH uptake
by the cysteine conjugate DCVC, which is also a substrate organic anion
transporter (Dantzler et al., 1995
, 1998
). The 1-min uptake of PAH in
tubule suspensions was reduced ~75% or more in the presence of CTFC
concentrations >0.5 mM. An interaction of 1 mM CTFC with the organic
anion pathway would be expected to produce a similar inhibition of
transepithelial fluorescein flux. As expected, 1 mM CTFC reduced the
flux of the organic anion substrate fluorescein by ~75% at all time
points examined. Thus, the inhibition of the basal-to-apical
transepithelial flux of fluorescein by CTFC, respectively, is probably
caused by the inhibition of carrier-mediated organic anion transport by
CTFC during the experimental observations.
Transepithelial flux involves the movement of substrate across both
poles of the renal cell. Thus, an inhibitor can block flux by
preventing substrate movement across one or both poles. The
intracellular accumulation of fluorescein was significantly reduced by
the addition of PAH or CTFC to the basal compartment, which also
suggests that CTFC interacts with basolateral organic anion transport
to block fluorescein transepithelial flux. The inhibition produced by
PAH was similar to the inhibition of fluorescein flux seen with CTFC
and demonstrates that CTFC is a potent inhibitor of basolateral organic
anion transport. Because fluorescein transport by the rabbit proximal
tubule appears to be mediated solely by the PAH pathway (Sullivan et
al., 1990
; Sullivan and Grantham, 1992
), the
trans-stimulation of fluorescein efflux across the peritubular membrane of suspensions of rabbit RPT by CTFC suggests that
CTFC is a substrate for the organic anion transporter. In contrast, the
minimal reabsorptive flux and hence the apical uptake of fluorescein
suggests that apical membrane accumulation of CTFC by the organic anion
pathway appears to play little functional role in CTFC accumulation
(data not shown). These results are in contrast to the findings from an
earlier study in which organic anion transport was concluded to play no
role in CTFC uptake, because probenecid failed to block CTFC toxicity
to rat RPT cells (Boogaard et al., 1989
). Because multiple pathways are
involved in CTFC transport by the RPT cell, the lack of probenecid
inhibition may simply reflect CTFC transport by a second pathway.
The uptake of the related cysteine conjugate DCVC by freshly isolated
rat RPT cells or LLC-PK1 cells was reduced ~60 and 96% by 5 and 1 mM
CTFC, respectively, which suggests these conjugates may share a common
transporter in these model systems (Schaeffer and Stevens, 1987a
; Lash
and Anders, 1989
). In rabbit S2 segments, PAH (5 mM) and probenecid (1 mM) reduced the basolateral membrane transport of DCVC ~60%. Also
DCVC stimulated PAH efflux in this model, which indicates that this
conjugate shares the organic anion pathway (Dantzler et al., 1998
). Rat
basolateral membrane vesicle transport of
S-(1,2-phenylhydroxyethyl)-L-cysteine
(PEC) also is mediated by the organic anion transporter (Chakrabarti et
al., 1991
). In contrast, 1 mM probenecid had no effect on basolateral DCVC uptake by suspensions of rat RPT (Zhang and Stevens, 1989
). Thus,
the organic anion transport system appears to mediate the basolateral
uptake of various cysteine conjugates, but the presence of a second
transport system that may be involved in cysteine conjugate uptake in
the basolateral membrane cannot be excluded. Just as CTFC had no effect
on the basolateral uptake of phenylalanine by rabbit RPT cells in this
study, phenylalanine also had no effect on the basolateral DCVC uptake
by rabbit S2 segments (Dantzler et al., 1998
). These data suggest that
the second basolateral membrane transport site may not be the
phenylalanine neutral amino acid pathway.
Previous studies have shown that the apical transport of the cysteine
conjugates DCVC and PCBC by proximal tubule cells and BBMV involves
amino acid transport pathways (Schaeffer and Stevens, 1987a
,b
; Mertens
et al., 1990
; Wright and Wunz, 1998
), whereas PEC accumulation is
mediated by apical organic anion transport (Chakrabarti et al., 1991
).
The apical-to-basal flux of phenylalanine was significantly reduced by
the addition of either unlabeled phenylalanine or CTFC to the apical
compartment. A concentration of 10 mM phenylalanine produced similar
inhibition to that produced by 1 mM CTFC, which suggests that CTFC is a
potent inhibitor of phenylalanine flux. The decreased intracellular
accumulation of phenylalanine indicates that CTFC primarily blocks the
influx of phenylalanine into the cell to reduce transepithelial flux. Interestingly, as mentioned earlier, no effect of CTFC on the basolateral uptake of phenylalanine was observed. These data suggest that the type of interaction between CTFC and phenylalanine transport differs in the apical and basolateral membranes. Phenylalanine efflux
across the apical membrane of cultures grown on impermeable membranes
(plastic) was trans-stimulated by CTFC, which implies that
these substrates share a common transport system in the apical membrane. The apical membrane transport of phenylalanine under physiological conditions appears to be mediated primarily by the Na-dependent neutral amino acid pathway (Silbernagl, 1988
). The interactions of CTFC with phenylalanine transport are therefore probably due to competition at a common binding site on the apical membrane neutral amino acid carrier.
Amino acid transport also has been reported to play a role in the
uptake of other cysteine conjugates. The uptake of PCBC reportedly
involves Na+-independent system T amino
acid transport in LLC-PK1 monolayers (Mertens et al., 1990
). On the
other hand, the transport of DCVC in LLC-PK1 cells is inhibited by
substrates for the Na+-independent system L amino
acid transporter and neutral amino acid substrates such as
phenylalanine. Similar to LLC-PK1 cells, the
Na+-dependent neutral amino acid pathway
transports DCVC in both rat and rabbit BBMV (Schaeffer and Stevens,
1987a
,b
; Wright and Wunz, 1998
). In contrast, the apical uptake of PEC
in isolated rat BBMV was mediated by organic anion transport
(Chakrabarti et al., 1991
). Apical organic anion uptake was minimal in
the current culture system, indicating that toxicant accumulation by
this pathway also would be minimal. These observations show that
variability, perhaps associated with structural differences, does seem
to exist in the pathways by which various cysteine conjugates cross the
renal membranes to enter the renal cell. However, some differences may
also be associated with species and or model system differences. In
spite of differences in mechanisms of toxicity in the rabbit RPT,
similarities do exist between the transport pathways by which DCVC and
CTFC access the RPT from the apical and basolateral compartments.
The haloalkane cysteine conjugate CTFC is biotransformed by the enzyme
cysteine conjugate
-lyase present within the cytoplasm and
mitochondria of renal cells (Hayden and Stevens, 1990
; Groves, 1991
;
Groves et al., 1991a
, 1993
). The entry of this toxicant into the RPT
cell is therefore paramount to the production of injury. Our study
demonstrates that CTFC uptake is mediated by both the neutral amino
acid and organic anion transport pathways in the apical and basolateral
membranes within the intact RPT cell. Any CTFC present in the systemic
circulation may access the RPT by glomerular filtration and/or the
peritubular capillaries in vivo to result in luminal or peritubular
exposure. These pathways may also serve as avenues for the efflux of
CTFC. However, further studies are required to understand the role of
these pathways in the overall influx, efflux, and intracellular
accumulation of CTFC within the RPT cell, as well as the role other
pathways may play in transport.
These data illustrate the usage of primary cultures grown on permeable supports to examine within one model system the interaction and transport of nephrotoxic cysteine conjugates with transport pathways in the apical and basolateral membrane of the RPT cell. The neutral amino acid transport pathway in the luminal membrane and the organic anion transporter in the basolateral membrane both appear to play a role in CTFC transport. These pathways may be critical to the entrance of cysteine conjugates to the renal cell and should be considered a prime site at which to concentrate efforts directed at the establishment of therapeutic protocols to prevent toxicity.
| |
Footnotes |
|---|
Accepted for publication July 22, 1999.
Received for publication April 23, 1999.
1 This work was supported by National Institutes of Health Award ES-08860 and an American Heart Association Faculty Development Award. Portions of this work were presented at the 37th annual Society of Toxicology meeting, Seattle, WA, March 1998.
Send reprint requests to: Dr. Carlotta E. Groves, University of Florida, College of Veterinary Medicine, Department of Physiological Sciences, Center for Environmental and Human Toxicology, P.O. Box 110885, Gainesville, FL 32611-0885. E-mail: grovesce{at}mail.vetmed.ufl.edu
| |
Abbreviations |
|---|
CTFC, S-(1-chloro-1,2,2-trifluoroethyl)-L-cysteine; BBMV, brush-border membrane vesicles; DCVC, S-(1,2-dichlorovinyl)-L-cysteine; FL-I, fluorescein isothiocyanate-inulin; PAH, p-aminohippurate; PCBC, S-(1,2,3,4,4-pentachlorobutadienyl)-L-cysteine; PEC, S-(1,2-phenylhydroxyethyl)-L-cysteine; RPT, renal proximal tubule; TFEC, S-(1,1,2,2-tetrafluoroethyl)-L-cysteine.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. E. Groves, L. Munoz, A. Bahn, G. Burckhardt, and S. H. Wright Interaction of Cysteine Conjugates with Human and Rabbit Organic Anion Transporter 1 J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 560 - 566. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||